Citigroup
KRSA

Citigroup’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Citigroup’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$352 Buy
+11
New +$305 ﹤0.01% 5603
2026
Q2 		– Sell
-13
Closed -$137 – 5835
2026
Q1 		$137 Sell
13
-1,159
-99% -$11.5K ﹤0.01% 5596
2025
Q4 		$10.4K Buy
+1,172
New +$14.6K ﹤0.01% 5041
2021
Q2 		– Sell
-10
Closed -$4K – 6168
2021
Q1 		$4K Sell
10
-21
-68% -$11K ﹤0.01% 5934
2020
Q4 		$13K Buy
31
+23
+288% +$11K ﹤0.01% 6856
2020
Q3 		$6K Sell
8
-15
-65% -$12K ﹤0.01% 6890
2020
Q2 		$19K Sell
23
-25
-52% -$14.6K ﹤0.01% 6646
2020
Q1 		$18K Sell
48
-13
-21% -$6.49K ﹤0.01% 6749
2019
Q4 		$23K Buy
61
+20
+49% +$13.1K ﹤0.01% 6865
2019
Q3 		$69K Sell
41
-4
-9% -$6.05K ﹤0.01% 5919
2019
Q2 		$71K Buy
+45
New +$89.1K ﹤0.01% 6162

Other funds holding KRSA

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Citigroup's KRSA Position: Q3 2026 in Review

Citigroup opened a new position in Korsana Biosciences, Inc. Common Stock (KRSA) in Q3 2026: 11 shares worth $352. The stake represents ﹤0.01% of the portfolio and ranks #5603 among its holdings. This is a return to the name: Citigroup previously reported a position in KRSA as recently as Q1 2026.

Citigroup first reported a position in KRSA in Q2 2019 and has held it in 11 quarters since. The position peaked at $71K in Q2 2019. 5 funds tracked by Wall St. Rank hold KRSA as of Q3 2026.

  • Citigroup held 11 shares of Korsana Biosciences, Inc. Common Stock worth $352 as of Q3 2026.
  • Korsana Biosciences, Inc. Common Stock was a new Citigroup position in Q3 2026.
  • Korsana Biosciences, Inc. Common Stock made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5603 holding.
  • Citigroup first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and has held it in 11 quarters since.
  • Citigroup's Korsana Biosciences, Inc. Common Stock position peaked at $71K in Q2 2019.
  • 5 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.